Skip to Content
  1. All products
  2. Weight Management
  3. AOD-9604
  4. Weight Management
Pricelist: Default Pricelist Pricelist
Pricelist: Default Pricelist Pricelist
AOD-9604

AOD-9604

Lyophilized Vial · Subcutaneous Refrigerate 2–8°C · 18-month shelf life 99% Purity · USP Grade
99% Purity
PHYSICIAN USE ONLY
$ 60.00 $ 60.00

Format
💉 vial
  • Strength
Add to cart
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days
Clinical Description

Fat loss, lipolysis stimulation, lipogenesis inhibition, stubborn fat reduction, weight management, body recomposition

AOD-9604 es un fragmento modificado de la hormona del crecimiento humano (HGH) desarrollado específicamente para la pérdida de grasa. Estimula la lipólisis (descomposición de grasas) e inhibe la lipogénesis (formación de grasas), lo que lo hace ideal para combatir las reservas de grasa rebeldes sin afectar los niveles de azúcar en sangre o IGF-1. AOD-9604 se utiliza comúnmente en protocolos de control de peso y recomposición corporal.

Clinical Indications
Fat Loss / LipolysisMetabolic OptimizationBody RecompositionCartilage RepairOsteoporosis Support
Recommended Stacking Protocols
✓
Tirzepatide
For appetite control
✓
Semaglutide
For appetite control
✓
5-Amino-1MQ
For metabolism and fat mobilization
✓
CJC-1295
For synergistic growth hormone stimulation

Mechanism of Action - Weight Management / Metabolic Pathway

Lipolysis Stimulation
Activates beta-3 adrenergic receptors in adipose tissue to directly stimulate fat breakdown.
Lipogenesis Inhibition
Inhibits synthesis of new fat from carbohydrates via diacylglycerol acyltransferase.
No IGF-1 / Glucose Effect
Does not stimulate IGF-1 or affect blood glucose — key safety advantage over full HGH.
Cartilage Support
Evidence for cartilage repair and anti-osteoporosis activity via HGH receptor binding.
Starting Dose
300-500mcg daily
Initiation phase for tolerance and baseline response.
Titration
300–600 mcg
Maintenance Range
300 mcg
Adjust based on objective outcomes and physician review.
Suggested Dosing Notes

Dosis estándar:300-500 mcg al día

Frecuencia:Una vez al día por la mañana o antes del entrenamiento.

Ciclo:Uso continuo o como parte de una fase de pérdida de grasa.

Period Dose Phase Clinical Notes
Standard Dose 300-500mcg daily maintenance Once daily in the morning or pre-workout. Ongoing use or as part of a fat-loss phase.
Week 3+ 300–600 mcg maintenance Adjust per response. 5 on / 2 off cycle.
Preparation Protocol
  1. AOD-9604 se suministra como polvo liofilizado.
  2. AOD-9604 debe reconstituirse con agua bacteriostática antes de su uso.
  3. El volumen de reconstitución varía ligeramente según el tamaño del vial para mantener una dosificación sencilla.
1
Verify Lyophilized Powder
Confirm the vial contains an intact white or off-white powder cake. Check lot number and expiration date.
2
Gather Sterile Supplies
Required: bacteriostatic water (BW), 1 mL insulin syringe, alcohol swabs, sharps container. Confirm all supplies are sterile and within date.
⚠️ Use only bacteriostatic water. Standard sterile water significantly reduces peptide stability.
3
Select Reconstitution Volume
Choose BW volume based on vial size and target concentration. See Reconstitution Guide tab for exact volumes per strength.
4
Reconstitute the Vial
Wipe stopper with alcohol swab. Inject BW slowly along the glass wall — never directly onto the powder. Allow liquid to run down the sides.
⚠️ Do not shake. Gently swirl or roll between palms (30–60 sec). Shaking causes irreversible peptide degradation.
5
Inspect & Store
Solution should be clear and colorless or slightly yellow. Discard if cloudy or particulate. Store reconstituted at 2–8°C, use within 28 days. Label with date.
Reconstitution & Dosing Guide
Standard 1 mL insulin syringe: 100 units = 1 mL

Total Peptide: 5 mg
BW: 1 mL
Concentration: 5mg/mL (50mcg per unit)
Dose Units to Draw Volume (mL) Approx. Supply
200mcg 4 units - ~25 doses (3+ weeks)
300mcg 6 units - ~16 doses (2+ weeks)
400mcg 8 units - ~12 doses (1.5 weeks)
500mcg 10 units - 10 doses (1.5 weeks)

Total Peptide: 10 mg
BW: 2 mL
Concentration: 5 mg/mL
Dose Units to Draw Volume (mL) Approx. Supply
300 mcg 6 0.06 mL 33 days
600 mcg 12 0.12 mL 16 days
Identity
  • Name: AOD-9604
  • Product Type: Vial | Subcutaneous Injection
  • CAS Number: 221231-10-3
  • Available Strengths: 5mg, 10mg
  • Molecular Formula: C₇₈H₁₂₃N₂₃O₂₃S₂
  • Molecular Weight: 1,817.0 Da
  • Sequence / Type: HGH fragment 176–191 (modified)
  • Available Strengths: 5mg, 10mg
Quality & Purity
  • Purity: 99%+
  • Purity: ≥ 99%
  • Endotoxin: ≤ 1 EU/mg
  • Appearance: White lyophilized powder
  • Solubility: Bacteriostatic water
Storage & Handling
  • Storage: Refrigerate after reconstitution (2-8°C)
  • Pre-use Storage: -20°C (long-term) / 2–8°C (short)
  • Post-Reconstitution: 2–8°C · Up to 28 days
  • Shelf Life: 18 months from manufacture

Timing: Frequency: Once daily in the morning orpre-workout

Storage: Refrigerate 2–8°C · 18-month shelf life

Frequency: StandardDose:300-500mcgdaily Frequency: Once daily in the morning orpre-workout

Cycle: Cycle:Ongoing use or as part of a fat-lossphase

Injection Sites: Rotate approved injection sites to reduce local irritation risk.